We’ve invested heavily in better cancer treatments and earlier diagnoses and we’re now seeing the results: over 18 million cancer survivors in the US. Survivors face ongoing challenges, with 74% experiencing physical and psychosocial side effects such as pain, fatigue, and distress. As survival rates climb, the demand for long-term care to manage side effects and prevent recurrence is outpacing the growth in supply.

​

Healthcare has been slow to adapt. Survivorship programs, proven to improve outcomes and reduce recurrence, are absent in most hospitals due to a lack of staff, limited expertise, insufficient infrastructure, and difficulty tracking patient outcomes. This leaves survivors navigating recovery alone, leading to worse health outcomes and higher costs across the system.

​​​

This challenge will only intensify. Cancer incidence is rising, in particular for younger generations, creating a growing population at high risk for late effects of treatment and potential cancer recurrence. Without adequate long-term support, these patients are likely to reenter the healthcare system in costly and preventable ways, affecting every stakeholder in oncology — from patients and providers to payers.

​

The After Cancer enables organizations to launch scalable, virtual survivorship programs by merging their clinical expertise with our technology. We deliver hyper-personalized care plans addressing patients’ side effects, mental health, and recurrence risk, while aligning oncology stakeholders to improve patient outcomes and lower costs through real-world data.